Questions for the Founders

The founders/management need to answer some simple but fundamental questions, and a what I see as a flaw in this model in my opinion.

If this was ONLY for the use by trained professionals, and ONLY for isolated environments, then why put the technology on an IPHONE????

Do you think that a Doctor wants to use their personal phone on dozens of patients per day?

Do you think that they want to sterilize their personal phone from bacterial and viral exposure after every patient's contamination?

Do you know the effect of hospital grade agents on equipment designed for continual sterilisation procedures, let alone the degradation effect on non-compliant equipment, materials and surfaces?

Do you think a consumer phone is designed for repeat sterilisation?

Do you think a specifically designed medical device to accommodate sterilisation would be more appropriate for such use?

Do you think that cross-contamination and infection control is an important aspect for adoption by the medical community?

Does your company endorse infection control, and consider it an important individual and community health aspect?

Have you clinically demonstrated that a Phone can be classed as sterile after repeat use on patients given the design intricacies, including buttons, crevices, microphones etc..?

Have to discussed infection control aspects with the regulators prior to moving down this design pathway and choice of data collection medium?

Do you think the feature set (microphone, acoustics etc..) would be better designed in a medical device for this specific diagnostic purpose that relying on a third party mobile phone?

Do you think disposal cover aspects are important in a clinical environment? (one would assume mandatory in hospitals and clinics).

Do you think the medical device option would be grossly cheaper than a $1000 IPHONE for such purposes?

Do you think the claims that this is for third world countries is flawed based on its use on an expensive mobile phone, and does that demographic have the means to purchase said phone for this very purpose?

How where these aspects above considered by the management, before embarking on the journey of putting this in a mobile phone app, using publicly sourced money?

Has management ever addressed these and if so what was the compounding rationale to use a phone over a medical device?

Do you think they plan to change the model before committing further funds for more clinical trial cost?